View Document Preview and Link Document Date: 2011-01-20 14:36:46 Open Document File Size: 415,40 KB Share Result on Facebook
City Reference / / Facility Laboratory Test Interactions / Laboratory Tests Response / / IndustryTerm gray rubber cap / treatment of advanced prostate cancer / Monitor for cardiovascular disease / injection site / treatment for patients with prostate cancer / mixed product / / MedicalCondition ureteral obstruction / paralysis / advanced prostate cancer / disease / sudden cardiac death / Hypersensitivity ELIGARD / vertebral metastases / hematuria / Carcinogenesis / Hyperglycemia / bladder outlet obstruction / cardiovascular disease / diabetes / Known hypersensitivity / pain / FATIGUE / myocardial infarction / diabetes mellitus / spinal cord compression / Anaphylactic reactions / Pregnancy WARNINGS AND PRECAUTIONS Tumor Flare Laboratory Tests Hyperglycemia / Hypersensitivity / prostate cancer / Cardiovascular diseases / paresthesia / Diabetes Hyperglycemia / / MedicalTreatment Counseling / / Organization DOSAGE AND ADMINISTRATION / / / Product leuprolide acetate / testosterone / ELIGARD / Injectable suspension / / Technology PHARMACOKINETICS / diagnostic tests / PHARMACODYNAMICS / / URL WWW.FDA.GOV/MEDWATCH / / SocialTag 
HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ELIGARD SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ELIGARD. ELIGARD (leuprolide acetate) suspensio